🔗 Share this article

A shadow market for unlicensed slimming medications is propelled by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Investigational Drug Gaining Popularity Via Social Media

The experimental drug, which remains in research studies, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are encouraged to contact these profiles directly for supplier links, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a flourishing market exists on Telegram, where groups with numerous of participants share “before and after” images, administration instructions and claims of next-day UK delivery. Vendors market the substance there before directing customers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Professionals Express Worries

However, physicians and chemists have cautions that the sale of what is still an unapproved drug in the UK is worrisome and could result in individuals administering substances of uncertain source.

Several experts stated the demand for retatrutide could be linked to the increasing price of licensed weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate medicines, marketing, and consumer regulations, risking fines, legal action or imprisonment.

Platform Reaction and Material Removal

Based on TikTok, the platform has taken down violative material and prohibited related hashtags and query recommendations. The company said it was dedicated to maintaining the platform secure and allocating resources in strengthening compliance measures.

Online Marketplace Operations

Investigations also discovered groups with up to nine thousand participants marketing the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, populated with photos of slimming results, glowing reviews and step-by-step instructions for preparing or administering at residence.

Within minutes of joining one group, a vendor shared WhatsApp details, where most purchases occur. The vendor sent an guidebook and promised shipping within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about body mass, medical conditions or previous experience.

Product Information and Costs

Inside these communities, messages show dark colored parcels with postal service labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how much time a injector should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A representative for Telegram said it regularly monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they cannot confirm. Even if the science behind this drug is sound, these online versions may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the conditions they were made in was sterile,” she explained.

Her staff has already seen patients harmed by self-injection from unverified suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly investigational product not yet approved … may expose patients to potentially significant medical dangers”.